Cost-benefit studies in psychiatry
Identifieur interne : 000161 ( Istex/Corpus ); précédent : 000160; suivant : 000162Cost-benefit studies in psychiatry
Auteurs : Anthony F. PanzettaSource :
- Comprehensive Psychiatry [ 0010-440X ] ; 1973.
Abstract
IT has been axiomatic for scientific psychiatry to beat its breast periodically about the relative lack of adequate research to answer the rather fundamental question: Does psychotherapy help? That deficit, although still painfully the case, has been narrowed by studies in increasing number and sophistication.1–4 The answer to the question above is still largely undetermined but there are gross impressions emerging which should lead us to at least tentative optimism.5 But as the work goes on in evaluation of psychotherapy, a new plaintive cry is being increasingly heard. We are now being urged to address ourselves to cost-effectiveness or cost-benefit studies. How much does it cost to get what? As is often the case when a concept gains popularity, it can quickly become reified and people behave as though the concept is magic. This has already begun with the concept “cost-benefit”. Having experienced the shattering effects of shifting fiscal priorities, the mental health establishment has hoisted a new banner. It is with an eye to this new magnificat that this paper is addressed. We shall first consider the concept of outcome research as applied to psychotherapy and to mental health delivery systems. Throughout these discussions we shall attempt to remain focused on those factors that are necessary for such studies and the inherent problems associated with this interest.
Url:
DOI: 10.1016/0010-440X(73)90016-3
Links to Exploration step
ISTEX:31CB05EEA63B5D33004F2957E21AADE2F0570E6ELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Cost-benefit studies in psychiatry</title><author><name sortKey="Panzetta, Anthony F" sort="Panzetta, Anthony F" uniqKey="Panzetta A" first="Anthony F." last="Panzetta">Anthony F. Panzetta</name><affiliation><mods:affiliation>Temple University Health Sciences Center, Philadelphia, Pa. 19140 USA.</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:31CB05EEA63B5D33004F2957E21AADE2F0570E6E</idno><date when="1973" year="1973">1973</date><idno type="doi">10.1016/0010-440X(73)90016-3</idno><idno type="url">https://api.istex.fr/document/31CB05EEA63B5D33004F2957E21AADE2F0570E6E/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000161</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000161</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Cost-benefit studies in psychiatry</title><author><name sortKey="Panzetta, Anthony F" sort="Panzetta, Anthony F" uniqKey="Panzetta A" first="Anthony F." last="Panzetta">Anthony F. Panzetta</name><affiliation><mods:affiliation>Temple University Health Sciences Center, Philadelphia, Pa. 19140 USA.</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Comprehensive Psychiatry</title><title level="j" type="abbrev">YCOMP</title><idno type="ISSN">0010-440X</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1973">1973</date><biblScope unit="volume">14</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="451">451</biblScope><biblScope unit="page" to="455">455</biblScope></imprint><idno type="ISSN">0010-440X</idno></series><idno type="istex">31CB05EEA63B5D33004F2957E21AADE2F0570E6E</idno><idno type="DOI">10.1016/0010-440X(73)90016-3</idno><idno type="PII">0010-440X(73)90016-3</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0010-440X</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">IT has been axiomatic for scientific psychiatry to beat its breast periodically about the relative lack of adequate research to answer the rather fundamental question: Does psychotherapy help? That deficit, although still painfully the case, has been narrowed by studies in increasing number and sophistication.1–4 The answer to the question above is still largely undetermined but there are gross impressions emerging which should lead us to at least tentative optimism.5 But as the work goes on in evaluation of psychotherapy, a new plaintive cry is being increasingly heard. We are now being urged to address ourselves to cost-effectiveness or cost-benefit studies. How much does it cost to get what? As is often the case when a concept gains popularity, it can quickly become reified and people behave as though the concept is magic. This has already begun with the concept “cost-benefit”. Having experienced the shattering effects of shifting fiscal priorities, the mental health establishment has hoisted a new banner. It is with an eye to this new magnificat that this paper is addressed. We shall first consider the concept of outcome research as applied to psychotherapy and to mental health delivery systems. Throughout these discussions we shall attempt to remain focused on those factors that are necessary for such studies and the inherent problems associated with this interest.</div></front></TEI><istex><corpusName>elsevier</corpusName><author><json:item><name>Anthony F. Panzetta</name><affiliations><json:string>Temple University Health Sciences Center, Philadelphia, Pa. 19140 USA.</json:string></affiliations></json:item></author><language><json:string>eng</json:string></language><abstract>IT has been axiomatic for scientific psychiatry to beat its breast periodically about the relative lack of adequate research to answer the rather fundamental question: Does psychotherapy help? That deficit, although still painfully the case, has been narrowed by studies in increasing number and sophistication.1–4 The answer to the question above is still largely undetermined but there are gross impressions emerging which should lead us to at least tentative optimism.5 But as the work goes on in evaluation of psychotherapy, a new plaintive cry is being increasingly heard. We are now being urged to address ourselves to cost-effectiveness or cost-benefit studies. How much does it cost to get what? As is often the case when a concept gains popularity, it can quickly become reified and people behave as though the concept is magic. This has already begun with the concept “cost-benefit”. Having experienced the shattering effects of shifting fiscal priorities, the mental health establishment has hoisted a new banner. It is with an eye to this new magnificat that this paper is addressed. We shall first consider the concept of outcome research as applied to psychotherapy and to mental health delivery systems. Throughout these discussions we shall attempt to remain focused on those factors that are necessary for such studies and the inherent problems associated with this interest.</abstract><qualityIndicators><score>4.596</score><pdfVersion>1.2</pdfVersion><pdfPageSize>476 x 720 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>0</keywordCount><abstractCharCount>1392</abstractCharCount><pdfWordCount>1980</pdfWordCount><pdfCharCount>13773</pdfCharCount><pdfPageCount>5</pdfPageCount><abstractWordCount>218</abstractWordCount></qualityIndicators><title>Cost-benefit studies in psychiatry</title><pii><json:string>0010-440X(73)90016-3</json:string></pii><genre><json:string>research-article</json:string></genre><host><volume>14</volume><pii><json:string>S0010-440X(00)X0035-1</json:string></pii><pages><last>455</last><first>451</first></pages><issn><json:string>0010-440X</json:string></issn><issue>5</issue><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><title>Comprehensive Psychiatry</title><publicationDate>1973</publicationDate></host><categories><wos><json:string>PSYCHIATRY</json:string></wos></categories><publicationDate>1973</publicationDate><copyrightDate>1973</copyrightDate><doi><json:string>10.1016/0010-440X(73)90016-3</json:string></doi><id>31CB05EEA63B5D33004F2957E21AADE2F0570E6E</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/31CB05EEA63B5D33004F2957E21AADE2F0570E6E/fulltext/pdf</uri></json:item><json:item><original>true</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/31CB05EEA63B5D33004F2957E21AADE2F0570E6E/fulltext/txt</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/31CB05EEA63B5D33004F2957E21AADE2F0570E6E/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/31CB05EEA63B5D33004F2957E21AADE2F0570E6E/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a">Cost-benefit studies in psychiatry</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>ELSEVIER</publisher><availability><p>ELSEVIER</p></availability><date>1973</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">Cost-benefit studies in psychiatry</title><author><persName><forename type="first">Anthony F.</forename><surname>Panzetta</surname></persName><note type="biography">Anthony F. Panzetta, M.D.: Associate Professor of Psychiatry, Director of the Psychiatric Outpatient Department, Temple University Health Sciences Center, Philadelphia, Pa. 19140.</note><affiliation>Anthony F. Panzetta, M.D.: Associate Professor of Psychiatry, Director of the Psychiatric Outpatient Department, Temple University Health Sciences Center, Philadelphia, Pa. 19140.</affiliation><affiliation>Temple University Health Sciences Center, Philadelphia, Pa. 19140 USA.</affiliation></author></analytic><monogr><title level="j">Comprehensive Psychiatry</title><title level="j" type="abbrev">YCOMP</title><idno type="pISSN">0010-440X</idno><idno type="PII">S0010-440X(00)X0035-1</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1973"></date><biblScope unit="volume">14</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="451">451</biblScope><biblScope unit="page" to="455">455</biblScope></imprint></monogr><idno type="istex">31CB05EEA63B5D33004F2957E21AADE2F0570E6E</idno><idno type="DOI">10.1016/0010-440X(73)90016-3</idno><idno type="PII">0010-440X(73)90016-3</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1973</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>IT has been axiomatic for scientific psychiatry to beat its breast periodically about the relative lack of adequate research to answer the rather fundamental question: Does psychotherapy help? That deficit, although still painfully the case, has been narrowed by studies in increasing number and sophistication.1–4 The answer to the question above is still largely undetermined but there are gross impressions emerging which should lead us to at least tentative optimism.5 But as the work goes on in evaluation of psychotherapy, a new plaintive cry is being increasingly heard. We are now being urged to address ourselves to cost-effectiveness or cost-benefit studies. How much does it cost to get what? As is often the case when a concept gains popularity, it can quickly become reified and people behave as though the concept is magic. This has already begun with the concept “cost-benefit”. Having experienced the shattering effects of shifting fiscal priorities, the mental health establishment has hoisted a new banner. It is with an eye to this new magnificat that this paper is addressed. We shall first consider the concept of outcome research as applied to psychotherapy and to mental health delivery systems. Throughout these discussions we shall attempt to remain focused on those factors that are necessary for such studies and the inherent problems associated with this interest.</p></abstract></profileDesc><revisionDesc><change when="1973">Published</change></revisionDesc></teiHeader></istex:fulltextTEI></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: tail"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType><istex:document><converted-article version="4.5.2" docsubtype="fla"><item-info><jid>YCOMP</jid><aid>73900163</aid><ce:pii>0010-440X(73)90016-3</ce:pii><ce:doi>10.1016/0010-440X(73)90016-3</ce:doi><ce:copyright type="unknown" year="1973"></ce:copyright></item-info><head><ce:title>Cost-benefit studies in psychiatry</ce:title><ce:author-group><ce:author><ce:given-name>Anthony F.</ce:given-name><ce:surname>Panzetta</ce:surname><ce:cross-ref refid="FN1"><ce:sup>1</ce:sup></ce:cross-ref></ce:author><ce:affiliation><ce:textfn>Temple University Health Sciences Center, Philadelphia, Pa. 19140 USA.</ce:textfn></ce:affiliation><ce:footnote id="FN1"><ce:label>1</ce:label><ce:note-para>Anthony F. Panzetta, M.D.: Associate Professor of Psychiatry, Director of the Psychiatric Outpatient Department, Temple University Health Sciences Center, Philadelphia, Pa. 19140.</ce:note-para></ce:footnote></ce:author-group><ce:abstract><ce:section-title>Abstract</ce:section-title><ce:abstract-sec><ce:simple-para><ce:bold>I</ce:bold>T has been axiomatic for scientific psychiatry to beat its breast periodically about the relative lack of adequate research to answer the rather fundamental question: Does psychotherapy help? That deficit, although still painfully the case, has been narrowed by studies in increasing number and sophistication.<ce:sup>1–4</ce:sup> The answer to the question above is still largely undetermined but there are gross impressions emerging which should lead us to at least tentative optimism.<ce:sup>5</ce:sup></ce:simple-para><ce:simple-para>But as the work goes on in evaluation of psychotherapy, a new plaintive cry is being increasingly heard. We are now being urged to address ourselves to cost-effectiveness or cost-benefit studies. How much does it cost to get what?</ce:simple-para><ce:simple-para>As is often the case when a concept gains popularity, it can quickly become reified and people behave as though the concept is magic. This has already begun with the concept “cost-benefit”. Having experienced the shattering effects of shifting fiscal priorities, the mental health establishment has hoisted a new banner. It is with an eye to this new magnificat that this paper is addressed.</ce:simple-para><ce:simple-para>We shall first consider the concept of outcome research as applied to psychotherapy and to mental health delivery systems. Throughout these discussions we shall attempt to remain focused on those factors that are necessary for such studies and the inherent problems associated with this interest.</ce:simple-para></ce:abstract-sec></ce:abstract></head></converted-article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo><title>Cost-benefit studies in psychiatry</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Cost-benefit studies in psychiatry</title></titleInfo><name type="personal"><namePart type="given">Anthony F.</namePart><namePart type="family">Panzetta</namePart><affiliation>Temple University Health Sciences Center, Philadelphia, Pa. 19140 USA.</affiliation><description>Anthony F. Panzetta, M.D.: Associate Professor of Psychiatry, Director of the Psychiatric Outpatient Department, Temple University Health Sciences Center, Philadelphia, Pa. 19140.</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="Full-length article"></genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1973</dateIssued><copyrightDate encoding="w3cdtf">1973</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">IT has been axiomatic for scientific psychiatry to beat its breast periodically about the relative lack of adequate research to answer the rather fundamental question: Does psychotherapy help? That deficit, although still painfully the case, has been narrowed by studies in increasing number and sophistication.1–4 The answer to the question above is still largely undetermined but there are gross impressions emerging which should lead us to at least tentative optimism.5 But as the work goes on in evaluation of psychotherapy, a new plaintive cry is being increasingly heard. We are now being urged to address ourselves to cost-effectiveness or cost-benefit studies. How much does it cost to get what? As is often the case when a concept gains popularity, it can quickly become reified and people behave as though the concept is magic. This has already begun with the concept “cost-benefit”. Having experienced the shattering effects of shifting fiscal priorities, the mental health establishment has hoisted a new banner. It is with an eye to this new magnificat that this paper is addressed. We shall first consider the concept of outcome research as applied to psychotherapy and to mental health delivery systems. Throughout these discussions we shall attempt to remain focused on those factors that are necessary for such studies and the inherent problems associated with this interest.</abstract><relatedItem type="host"><titleInfo><title>Comprehensive Psychiatry</title></titleInfo><titleInfo type="abbreviated"><title>YCOMP</title></titleInfo><genre type="Journal">journal</genre><originInfo><dateIssued encoding="w3cdtf">197309</dateIssued></originInfo><identifier type="ISSN">0010-440X</identifier><identifier type="PII">S0010-440X(00)X0035-1</identifier><part><date>197309</date><detail type="volume"><number>14</number><caption>vol.</caption></detail><detail type="issue"><number>5</number><caption>no.</caption></detail><extent unit="issue pages"><start>387</start><end>474</end></extent><extent unit="pages"><start>451</start><end>455</end></extent></part></relatedItem><identifier type="istex">31CB05EEA63B5D33004F2957E21AADE2F0570E6E</identifier><identifier type="DOI">10.1016/0010-440X(73)90016-3</identifier><identifier type="PII">0010-440X(73)90016-3</identifier><recordInfo><recordContentSource>ELSEVIER</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/MagnificatV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000161 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000161 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Musique
|area= MagnificatV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:31CB05EEA63B5D33004F2957E21AADE2F0570E6E
|texte= Cost-benefit studies in psychiatry
}}
| This area was generated with Dilib version V0.6.31. |  |